Delivery Order SPE2DB24D2212-SPE2DB25FHNEE
Award Date
11/7/24
Potential Completion Date
11/8/24
Potential Value
$5.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,366.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Glimepiride 4 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of June 13, 2024 and is a firm fixed-price delivery order. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,529.84 fixed-price delivery order is for the supply of 4 mg glimepiride tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of February 21, 2025 and was awarded on February 20, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $1,281.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Glimepiride 2 mg tablets, a medication used to treat type 2 diabetes. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,044.95 firm fixed-price delivery order is for 4,565,549,549 units of the drug Glimepiride 4 mg tablets, which are used to treat diabetes. The contract has an ultimate completion date of August 23, 2024. The award is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $2,960.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a medication used in the management of diabetes. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,546.94 Firm Fixed Price delivery order is for the supply of 4 mg glimepiride tablets, a medication used to treat diabetes. The contract has an ultimate completion date of May 23, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $2,751.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Glimepiride 2 mg tablets, a medication used to treat diabetes. The award is a Firm Fixed Price Delivery Order with a completion date of March 8, 2024. The contract does not have a set-aside designation, indicating it was open competition. AmerisourceBergen...
This federal contract award, valued at $8,413.78, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4 mg Glimepiride tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of November 14, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,386.08 firm-fixed-price delivery order is for the supply of 4 mg glimepiride tablets, a medication used to treat diabetes. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,316.81 firm fixed-price delivery order is for the supply of 4 mg glimepiride tablets, a medication used to treat type 2 diabetes. The award has an ultimate completion date of December 30, 2024 and was made on December 27, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...